首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord? [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD
【24h】

A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord? [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD

机译:镰状细胞疾病(SCD)的新疗法:尼古德的共同移植? [exVivo扩增脐带血(UCB)祖细胞与烟酰胺]和非规划的不相关的UCB移植物导致成功的植入和严重SCD的固化

获取原文
获取原文并翻译 | 示例
           

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号